Trial NCT00924287

View at ClinicalTrials.gov 
Aliases: NCT00805987
Org. Study IDs: 090041
Secondary IDs: 09-C-0041

Last trial update was posted on 2015-10-28

MeSH Interventions

Aldesleukin Cyclophosphamide Fludarabine Interleukin-2 Mesna

MeSH Conditions

Neoplasm Metastasis Neoplasms Neoplasms, Second Primary

Other Conditions

Metastatic Cancer

Stopping Reasons

This study was terminated after the first patient treated on study died as a result of the treatment.

Limitations And Caveats

This study was terminated after the first patient on study died as a result of the treatment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID